While the debate on alcohol consumption may continue, the evidence of its harmful effects is clear. From gastrointestinal ...
Triveni Bio Inc., a biotech company advancing novel antibody treatments for I&I disorders, today announced a $115 million ...
This article will explore what pancreatitis is, both acute and chronic. Discover what sets off this condition, it telltale signs and the diverse approaches to treatment, including medical procedures, ...
Agents like semaglutide show promise for treatment of substance use disorders. Inaccessibility of GLP-1 agonists due to high ...
Zhejiang Doer Biologics Co., Ltd. ("Doer Bio"), a clinical stage biopharmaceutical company developing innovative ...
U.S. FDA Approves Bristol Myers Squibb’s COBENFY, a First-In-Class Muscarinic Agonist for the Treatment of Schizophrenia in Adults ...